CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities:
Net income	$ 18,038	$ 8,326
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	(821)	11,127
Depreciation and amortization of premises and equipment	1,608	1,504
Non-cash lease (benefit) expense	(28)	59
Cash flows from operating leases	(1,599)	(1,594)
Loss on disposal of fixed assets	32	0
Loss on sale of other real estate, net of write-downs	0	64
Amortization of mortgage servicing rights	1,232	1,547
Net amortization and accretion of premium/discounts on investment securities	2,391	1,982
Share-based compensation expense	879	673
Net gain on sales of residential mortgage loans	(2,439)	(727)
Proceeds from sales of loans held for sale	57,439	31,498
Originations of loans held for sale	(43,547)	(25,598)
Equity in earnings of unconsolidated subsidiaries	(107)	(26)
Distributions from unconsolidated subsidiaries	181	73
Net (increase) decrease in cash surrender value of bank-owned life insurance	(898)	19
Deferred income taxes	(6,687)	(406)
Net tax benefit (expense) from share-based compensation	131	(48)
Net change in other assets and liabilities	(6,126)	2,772
Net cash provided by operating activities	19,679	31,245
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available-for-sale	80,015	50,878
Purchases of investment securities available-for-sale	(139,785)	(96,068)
Net loan originations	(138,572)	(41,339)
Purchases of loan portfolios	(36,059)	(22,340)
Purchases of bank-owned life insurance	(3,550)	0
Proceeds from bank-owned life insurance	499	0
Net purchases of premises, equipment and land	(8,961)	(5,608)
Contributions to unconsolidated subsidiaries	(2,736)	(422)
Net proceeds from redemption of (purchases of) FHLB stock	82	(3,126)
Net cash used in investing activities	(249,067)	(118,025)
Cash flows from financing activities:
Net increase in deposits	412,832	16,046
Net (decrease) increase in short-term borrowings	(22,000)	72,000
Cash dividends paid on common stock	(6,490)	(6,496)
Repurchases of common stock and other related costs	0	(4,749)
Net proceeds from issuance of common stock and stock option exercises	870	0
Net cash provided by financing activities	385,212	76,801
Net increase (decrease) in cash and cash equivalents	155,824	(9,979)
Cash and cash equivalents at beginning of period	104,067	102,972
Cash and cash equivalents at end of period	259,891	92,993
Cash paid during the period for:
Interest	1,681	6,140
Income taxes	$ 2,445	$ 170

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.